UPC CFI 233/2023
7. Juli 2023·EP3797685 · SYSTEMS AND METHODS FOR DISPLAY DEVICE AND SENSOR ELECTRONICS UNIT COMMUNICATION
Hauptaktenzeichen: ACT 547520/2023
- Verfahrensdetails
- StatusCase Closed (Keine Verletzung)VerfahrensartVerletzungKategorieHauptverletzungsklage
- Parteien
- Kläger
- Dexcom Inc.Unternehmen
Vertreter- Marcus Grosch-Quinn Emanuel Urquhart & Sullivan LLP
- Alexander Esslinger-Betten & Resch Partnerschaftsgesellschaft mbB
- Nicht genannt-Quinn Emanuel Urquhart & Sullivan LLP
Beklagte- Abbott LaboratoriesUnternehmen
- Abbott Diabetes Care Inc.Unternehmen
- Abbott GmbHUnternehmen
- Abbott Diagnostics GmbHUnternehmen
- Abbott Logistics B.V.Unternehmen
- Abbott (S.A./N.V.)Unternehmen
- Abbott s.r.l.Unternehmen
- Abbott B.V.Unternehmen
- Abbott Scandinavia AktiebolagUnternehmen
- Abbott FranceUnternehmen
Vertreter- Wim Maas-Taylor Wessing
- Division
- Munich LD
- Technologie
- Electrical engineeringDigital communication
- InstrumentsMedical technology
- Sprache
- English
- Erste Entscheidung
- 31. Juli 2024
| Verletzung festgestellt | Median Tage bis zur ersten Entscheidung | |
|---|---|---|
| Gesamt-UPC | 53% (62/117) | 124 |
| Munich LD | Gesperrt | Gesperrt |
| Richter Matthias Zigann | Gesperrt | Gesperrt |
| Richter Tobias Pichlmaier | Gesperrt | Gesperrt |
| Richter Tatyana Zhilova | Gesperrt | Gesperrt |
| Richter Alain Dumont | Gesperrt | Gesperrt |
Vor dem UPC: Dexcom Group (39 Verfahren)·Abbott Group (67 Verfahren)
Dieser Streit umfasst 6 weitere Verfahren
UPC CoA 569/2024·UPC APP 49196/2024·UPC APP 45331/2024·CC 586829/2023·CC 586960/2023 und 1 weitere
Starten Sie die kostenlose Testphase, um die Ausgänge zu sehen.
- —revocation counterclaim
Zusammenfassung: 1. EP 3 797 685 B1 is entirely revoked with effect in the territories of the Contracting Member States for which the European Patent had effect at the time of the counterclaim for revocation, namely [17 states]. 2. The auxiliary requests are dismissed. ... 4. All infringement claims are dismissed.
| Dokumenttitel | Datum | Öffentlich |
|---|---|---|
| workflow closed | 2025-07-22 | Öffentlich |
| workflow closed | 2025-07-22 | Nicht öffentlich |
| workflow closed | 2025-07-22 | Öffentlich |
| workflow closed | 2025-07-22 | Nicht öffentlich |
| workflow closed | 2025-07-22 | Öffentlich |
| workflow closed | 2025-07-22 | Nicht öffentlich |
| Outcome of the Order | 2025-04-17 | Nicht öffentlich |
| workflow closed | 2025-04-17 | Öffentlich |
| Consent | 2025-01-16 | Nicht öffentlich |
| Comment on withdrawal | 2025-01-14 | Nicht öffentlich |
DexCom Inc. brought an infringement action against multiple Abbott entities before the Munich Local Division concerning EP 3 797 685 (a CGM system patent). Abbott counterclaimed for revocation and succeeded: the court found the patent invalid for lack of novelty/inventive step both as granted and in DexCom's two auxiliary request forms, and revoked it entirely. DexCom's failure to advance specific arguments distinguishing the dependent claims was noted as a further reason those claims fell. All infringement claims were dismissed and DexCom was ordered to bear all costs.
Patent EP 3 797 685 invalid as granted and in all auxiliary request forms
BeklagterRechtsgrundlage: Art. 138(1) EPC; Art. 65(2) UPCAHinweis: Munich LD upheld Abbott's counterclaim for revocation, finding the CGM patent invalid for lack of novelty/inventive step in all claim versions.
Dependent claims are invalid for same reasons as claim 1 where claimant provides no specific arguments distinguishing dependent claims
BeklagterRechtsgrundlage: Art. 138(1) EPCHinweis: Claimant merely asserted dependent claims contain claim 1 features and are novel/inventive for the same reasons; no specific arguments advanced; court held dependent claims also invalid.
EP 3 797 685 as granted is valid
KlägerRechtsgrundlage: Art. 54/56 EPCBegründung: Patent found invalid for lack of novelty/inventive step as granted.
Auxiliary requests 1 and 2 are valid
KlägerRechtsgrundlage: Art. 54/56 EPCBegründung: Both auxiliary requests also found invalid; dismissed.
Weitere Fälle zu diesem Grundsatz ansehen.